Aviragen Therapeutics (AVIR) Earnings
|
Expand Research on AVIR
| Next EPS Date | 11/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -7.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.55 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/26 | Q226 | -$0.41 | -$0.56 | +$0.15 | N/A | N/A | N/A |  | | Details | |
| 8/6/26 |
Q226 | N/A | -$0.56 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.57 | -$0.56 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 3/5/26 | Q425 | -$0.57 | -$0.44 | -$0.13 | N/A | N/A | N/A | | | Details | |
| 11/12/25 | Q325 | -$0.53 | -$0.42 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.42 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.42 | N/A | N/A | N/A | N/A | N/A | N/A |
